Biomarin Pharmaceutical | 8-K: Current report
16:16 ET
Biomarin Pharmaceutical | 4: Statement of changes in beneficial ownership of securities-Director BIENAIME JEAN JACQUES
Apr 15 16:26 ET
Biomarin Pharmaceutical | 4: Statement of changes in beneficial ownership of securities-Officer Burkhart Erin
Apr 12 15:13 ET
Biomarin Pharmaceutical | 144: Notice of proposed sale of securities pursuant to Rule 144
Apr 12 09:52 ET
Biomarin Pharmaceutical | 144: Notice of proposed sale of securities pursuant to Rule 144
Apr 11 09:59 ET
Biomarin Pharmaceutical | 144: Notice of proposed sale of securities pursuant to Rule 144
Apr 10 15:58 ET
Biomarin Pharmaceutical | DEF 14A: Definitive information statements
Apr 9 22:19 ET
Biomarin Pharmaceutical | ARS: Annual Report to Security Holders
Apr 9 16:26 ET
Biomarin Pharmaceutical | DEFA14A: Others
Apr 9 16:13 ET
Biomarin Pharmaceutical | 4: Statement of changes in beneficial ownership of securities-Officer Davis George Eric
Apr 1 17:07 ET
Biomarin Pharmaceutical | 144: Notice of proposed sale of securities pursuant to Rule 144
Mar 28 15:29 ET
Biomarin Pharmaceutical | 4: Statement of changes in beneficial ownership of securities-Director Slamon Dennis
Mar 20 17:18 ET
Biomarin Pharmaceutical | 4: Statement of changes in beneficial ownership of securities-Officer Burkhart Erin
Mar 19 20:58 ET
Biomarin Pharmaceutical | 4: Statement of changes in beneficial ownership of securities-Officer Davis George Eric
Mar 19 20:57 ET
Biomarin Pharmaceutical | 4: Statement of changes in beneficial ownership of securities-Officer Guyer Charles Greg
Mar 19 20:53 ET
Biomarin Pharmaceutical | 4: Statement of changes in beneficial ownership of securities-Officer Mueller Brian
Mar 19 20:53 ET
Biomarin Pharmaceutical | 4: Statement of changes in beneficial ownership of securities-Officer FUCHS HENRY J
Mar 19 20:48 ET
Biomarin Pharmaceutical | 4: Statement of changes in beneficial ownership of securities-Officer Hardy Alexander
Mar 19 20:48 ET
Biomarin Pharmaceutical | 4: Statement of changes in beneficial ownership of securities-Director BIENAIME JEAN JACQUES
Mar 19 20:43 ET
Biomarin Pharmaceutical | 4: Statement of changes in beneficial ownership of securities-Officer Ajer Jeffrey Robert
Mar 19 20:38 ET
No Data
No Data